calcium aminosalicylate
Small moleculeexperimental
4-Aminosalicylic acid, also known as para-aminosalicylic acid (PAS) and sold under the brand name Paser among others, is an antibiotic primarily used to treat tuberculosis. Specifically it is used to treat active drug resistant tuberculosis together with other antituberculosis medications. It has also been used as a second line agent to sulfasalazine in people with inflammatory bowel disease such as ulcerative colitis and Crohn's disease. It is typically taken by mouth. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 8, 2019 (NCT03830671)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Loading structure…
SMILES
Nc1ccc(C(=O)[O-])c(O)c1.Nc1ccc(C(=O)[O-])c(O)c1.[Ca+2]- Mol. weight
- 344.34 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- Wikipedia4-Aminosalicylic acid ↗
- ChEMBLCHEMBL2105983 ↗
Also known as
- aminosalicylate calcium
- aminosalicylate calcium
- calcium aminosalicylate
- calcium aminosalicylate
- calcium aminosalicylate
- calcium para-aminosalicylate
- calcium para-aminosalicylate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03830671 | N/A | Mar 8, 2019 | Capital Medical University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 1 | 1 | 2019 |
1 organizations
Page 1 / 1